BDBM326296 4-{[(1R)-1- cyclobutylethyl]amino}- 6-[4-(1- methylethyl)pyridin-2- yl]-5-[4- (trifluoromethyl)benzyl]- 5H-pyrrolo[3,2- d]pyrimidine-2- carboxylic acid::US9637493, 1.10

SMILES CC(C)c1ccnc(c1)-c1cc2nc(nc(N[C@H](C)C3CCC3)c2n1Cc1ccc(cc1)C(F)(F)F)C(O)=O

InChI Key InChIKey=WGNSFENCDDRRRJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 326296   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM326296(4-{[(1R)-1- cyclobutylethyl]amino}- 6-[4-(1- methy...)
Affinity DataIC50: 26nMAssay Description:Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/29/2019
Entry Details
Go to US Patent